Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD.

MLA

Grootendorst, Diana C., et al. “Reduction in Sputum Neutrophil and Eosinophil Numbers by the PDE4 Inhibitor Roflumilast in Patients with COPD.” Thorax, vol. 62, no. 12, Dec. 2007, pp. 1081–87. EBSCOhost, https://doi.org/10.1136/thx.2006.075937.

APA

Grootendorst, D. C., Gauw, S. A., Verhoosel, R. M., Sterk, P. J., Hospers, J. J., Bredenbröker, D., Bethke, T. D., Hiemstra, P. S., & Rabe, K. F. (2007). Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD. Thorax, 62(12), 1081–1087. https://doi.org/10.1136/thx.2006.075937

Chicago

Grootendorst, Diana C, Stefanie A Gauw, Renate M Verhoosel, Peter J Sterk, Jeannette J Hospers, Dirk Bredenbröker, Thomas D Bethke, Pieter S Hiemstra, and Klaus F Rabe. 2007. “Reduction in Sputum Neutrophil and Eosinophil Numbers by the PDE4 Inhibitor Roflumilast in Patients with COPD.” Thorax 62 (12): 1081–87. doi:10.1136/thx.2006.075937.